![]()
|
|
||||||||
J. Biol. Chem., Vol. 277, Issue 21, 18454-18458, May 24, 2002
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the
Received for publication, January 15, 2002, and in revised form, March 5, 2002
A new gene (POLL), has been
identified encoding the novel DNA polymerase Eukaryotic cells contain several DNA polymerases
(pol)1 classified as
classical pols ( Recombinant murine pol Pol Chromatographic Media and Other Chemicals--
Phosphocellulose
P11 was obtained from Whatman, hydroxyapatite from Bio-Rad, HiTrap
Desalting, HiTrap heparin, mono Q, and mono S columns from
Amersham Biosciences. Pepstatin, leupeptin, and aphidicolin were
obtained from Sigma. All other reagents were of analytical grade and
purchased from Merck or Fluka.
Buffers--
All stock solutions were filtered
through nitrocellulose before use (0.45 µm, Schleicher & Schüll). The following buffers were used: buffer 1 (50 mM Tris-HCl, pH 7.0, 50 mM NaCl, 20% (w/v) sucrose, 1 mM DTT, 2 mM EDTA, 5 µg/ml
pepstatin, 1 µg/ml leupeptin, 0.8 mM PMSF); buffer 2 (50 mM Tris-HCl, pH 7.0, 50 mM NaCl, 1% (v/v) Triton X-100, 1 mM DTT, 2 mM EDTA, 5 µg/ml pepstatin, 1 µg/ml leupeptin, 0.8 mM PMSF);
buffer 3 (50 mM Tris-HCl, pH 7.0, 1 mM DTT, 2 mM EDTA, 10% (v/v) glycerol, 5 µg/ml pepstatin, 1 µg/ml leupeptin, 0.8 mM PMSF, and different molar
concentrations of NaCl), buffer 4 (50 mM Tris-HCl, pH 7.0, 1 mM DTT, 2 mM EDTA, 10% (v/v) glycerol, 5 µg/ml pepstatin, 1 µg/ml leupeptin, 0.8 mM PMSF, and
different molar concentrations of potassium phosphate); buffer 5 (50 mM Tris-HCl, pH 7.5, 1 mM DTT, 2 mM
EDTA, 10% (v/v) glycerol, 5 µg/ml pepstatin, 1 µg/ml leupeptin,
0.8 mM PMSF, and different molar concentrations of NaCl).
Preparation of Nucleic Acids--
Amersham Biosciences was the
supplier of poly(dA) and oligo(dT)12-18. The
homopolymer poly(dA) was mixed to the oligomer oligo(dT)12-18 at a 10:1 base ratio in 20 mM
Tris, pH 8.0, 20 mM KCl, and 1 mM EDTA heated
at 60 °C for 5 min with subsequent slow cooling to room temperature.
Damaged (Apurinic) DNA Template Preparation and
Characterization--
To create apurinic sites, the DNA template poly
d(A)/oligo d(T) at a 10:1 base ratio was incubated at a final
concentration of 0.25 mg/ml at 70 °C in the following buffer: 10 mM sodium citrate, 10 mM NaCl, and 10 mM NaH2PO4, pH 5.2. This treatment
specifically hydrolyzes the glycosidic bond between the purine base and
the deoxyribose moiety, releasing the base without interrupting the continuity of the sugar-phosphate backbone. The degree of DNA damage
was checked at different incubation times by monitoring the loss of DNA
synthesis efficiency by pols Antibodies--
The mouse monoclonal antibody against rat pol
DNA Polymerase Assays--
A final volume of 25 µl contained
the following components: 50 mM bis-Tris, pH 6.5, 1 mM DTT, 250 µg/ml bovine serum albumin, 6 mM
MgCl2, 10 mM KCl, 20 µM
[3H]dTTP, 0.5 µg of
poly(dA)/oligo(dT)12-18 (10:1 base ratio) or 0.1 µg of
depurinated poly(dA)/oligo(dT)12-18 (10: 1 base ratio) and
enzyme to be tested. 1 unit of enzyme activity corresponds to the
incorporation of 1 nmol of dTTP into acid-precipitable material in 60 min at 37 °C.
Purification of a DNA Polymerase Activity That Preferentially
Uses a Damaged DNA Template--
All enzymatic pol tests were
performed with poly d(A)/oligo (dT)12-18 or with damaged
poly d(A)/oligo (dT)12-18, and isolation steps were
performed at or near 0 °C. 70 g of calf thymus were resuspended
in 210 ml of buffer 1 and homogenized in a Sorvall Omnimixer. After
centrifugation in a GSA rotor at 12,000 rpm for 45 min, the pellet was
washed additionally in buffer 1. This pellet (35 g) was resuspended in
140 ml of buffer 2, homogenized, rotated for 2 h, and centrifuged
at 12,000 rpm for 45 min. The supernatant (detergent extract) was
brought to pH 7.0 to yield fraction I. Fraction I was loaded onto a
60-ml P11 phosphocellulose column, equilibrated previously in buffer 3 with 50 mM NaCl. The column was first washed with 600 ml of
buffer 3 (50 mM NaCl), and the proteins were eluted with
500 ml of a linear 50-700 mM gradient of NaCl in buffer 3. The peak fractions containing pol activity on damaged DNA eluted
between 220 and 300 mM NaCl and were pooled to yield
fraction II. Fraction II was adsorbed to a 6-ml hydroxyapatite column,
equilibrated previously in buffer 4. After washing with 10 column
volumes of buffer 4 with 20 mM potassium phosphate, a
10-column volume of a linear 20-500 mM potassium phosphate
gradient in buffer 4 was developed. On this column, separation of pols
that do not synthesize on the damaged template was achieved (see Fig.
1A). The pol activity on the damaged template was eluted
between 250 and 350 mM potassium phosphate, pooled, and
desalted to yield fraction III. Fraction III was loaded on a 1-ml
HiTrap heparin column equilibrated in buffer 3 (50 mM NaCl), the column was washed with 6 ml of buffer 3 (50 mM
NaCl), and the pol activity was eluted with a 40-ml linear gradient of 50-1000 mM NaCl in buffer 3. The active fractions were
eluted between 550 and 650 mM NaCl, pooled, and desalted to
yield fraction IV. Fraction IV was loaded onto a fast protein liquid
chromatography mono Q column, equilibrated in buffer 5 (50 mM NaCl), washed with 5 ml of buffer 5 (50 mM
NaCl), and eluted with a 15-ml 50-1000 mM NaCl
linear gradient in buffer 5. The active fractions were eluted between
380 and 500 mM NaCl, pooled, and desalted to yield fraction
V. Fraction V was loaded onto a fast protein liquid chromatography mono
S column, equilibrated in buffer 5 (50 mM), and washed with 5 ml of buffer 5 (50 mM NaCl). The pol activity was eluted
with a 10-ml 50-500 mM linear gradient in buffer 5 as a
homogeneous peak. The active fractions were immediately frozen in small
aliquots to Fidelity Assay--
Bacteriophage M13mp2 and Escherichia
coli strains CSH50, NR9099, and MC1061 were as described in Ref.
6. Nonsense mutant M13mp2T90 (point mutation G:T in the position +90
of the lacZ gene) was selected after sequencing
analysis of colorless mutants as a mutation hot point in the DNA M13mp
forward mutation assay. The sequence of the 26-mer oligonucleotide was:
5'-cga tta agt tgg gta acg cca ggg tt-3'. This oligonucleotide was
hybridized in addition to the gap molecules (the 3'-end of the primer
being located as three nucleotides from the point substitution T in the
nonsense mutant instead of G in M13mp2 DNA at position +90 of
lacZ gene) to verify that in every case, the nucleotides
were incorporated in the nonsense codon TAA. Forward and reverse
mutation assays were done according to Ref. 6. Replication reactions for the forward mutation assay were carried out for 2 h at
37 °C in 10 µl containing: 5 mM MgCl2, 50 mM Tris-HCl, pH 7.2, 1 mM DTT, 100 µg/ml
bovine serum albumin, 40 ng of gapped circular M13mp2 DNA, 20 µM each of dATP, dCTP, dGTP, and dTTP, and 0.03 units of
either pol Other Methods--
The following three methods were carried out
according to established protocols: SDS-PAGE (7), immunoblotting (8),
and in situ polymerase activity gel analysis (9).
Purification of a 67-kDa DNA Polymerase from Calf Thymus Detergent
Extract That Preferentially Replicates Damaged DNA--
Calf thymus
detergent extract was fractionated using a damaged DNA as the template
for measuring DNA polymerase activity (see "Materials and
Methods"), and DNA polymerase activity was monitored through
different chromatographic steps (Fig.
1A). On the second purification step, a peak eluting between 250 and 350 mM
potassium phosphate, which had a similar activity on both the
non-damaged and damaged DNA, was separated by the bulk of DNA
polymerase activity (Fig. 1B). This activity was then
purified through HiTrap Heparin-Sepharose, mono Q and mono S columns.
The resulting peak fractions (Fig. 1C) were analyzed on
SDS-PAGE and showed a single band of 67 kDa (Fig. 1D).
Identification of the 67-kDa DNA Polymerase as DNA Polymerase
It has been reported that N-terminal domain of pol Biochemical Properties of DNA Polymerase Fidelity of DNA Polymerases We thank L. Blanco for polyclonal antibodies
against mouse pol *
This work was supported by Grant 3100. 061361. 00 from the
Swiss National Science Foundation and by the Kanton of Zürich.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
Published, JBC Papers in Press, March 8, 2002, DOI 10.1074/jbc.M200421200
The abbreviations used are:
pol, polymerase;
BER, base excision repair;
DTT, dithiothreitol;
PMSF, phenylmethylsulfonyl fluoride.
DNA Polymerase
from Calf Thymus Preferentially Replicates
Damaged DNA*
,
§,
Institute of Veterinary Biochemistry and
Molecular Biology, University of Zürich-Irchel,
Winterthurerstrasse 190, CH-8057, Zürich, Switzerland,
§ Department of Molecular and Radiation Biophysics,
Petersburg Nuclear Physics Institute, Leningrad district, Gatchina,
188300, Russia, and ¶ Istituto di Genetica Molecolare,
Consislio Nationale dell Ricerche, Via Abbiategrasso 207, I-27100, Pavia, Italy
![]()
ABSTRACT
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS AND DISCUSSION
REFERENCES
and mapped to
mouse chromosome 19 and at human chromosome 10. DNA polymerase
contains all the critical residues involved in DNA binding, nucleotide
binding, nucleotide selection, and catalysis of DNA polymerization and
has been assigned to family X based on sequence homology with
polymerase
,
, µ, and terminal deoxynucleotidyltransferase.
Here we describe a purification of DNA polymerase
from calf thymus
that preferentially can replicate damaged DNA. By testing polymerase
activity on non-damaged and damaged DNA, DNA polymerase
was
purified trough five chromatographic steps to near homogeneity and
identified as a 67-kDa polypeptide that cross-reacted with
monoclonal antibodies against DNA polymerase
and polyclonal
antibodies against DNA polymerase
. DNA polymerase
had no
detectable nuclease activities and, in contrast to DNA polymerase
,
was aphidicolin-sensitive. DNA polymerase
was a 6-fold more
accurate enzyme in an M13mp2 forward mutation assay and 5-fold more
accurate in an M13mp2T90 reversion system than human recombinant DNA
polymerase
. The biochemical properties of the calf thymus DNA
polymerase
, described here for the first time, are discussed in
relationship to the proposed role for this DNA polymerase
in vivo.
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS AND DISCUSSION
REFERENCES
,
,
,
, and
) and novel pols (
,
,
,
,
,
,
, and µ) (1). Novel pols have so far never been purified directly from mammalian tissues.
(67 kDa) is a protein composed of 573 amino acids and is highly similar to the members of the pol family X
(2) comprising enzymes involved in the DNA repair processes, whose main
member is pol
. The first 239 amino acids of the N-terminal part of
pol
with the exception of the nuclear localization signal have no
counterpart in pol
. This N-terminal part of pol
has similarity
to yeast pol IV and contains a BRCA1 C-terminal (BRCT) domain
(2). The BRCT domain is present in several proteins involved in DNA
repair and cell cycle checkpoint control (3, 4). Recently, it has been
shown that the BRCT domain is involved in protein/protein interactions
(4). The remaining part of pol
is composed of the catalytic core,
which is similar to pol
(8-kDa DNA
deoxyribophosphodiesterase domain and 32-kDa finger, palm, and
thumb-polymerization domain) and has 32% amino acid identity to pol
(2).
contains 5'-deoxyribose phosphate lyase activity, but no
apurinic lyase activity (5), and can substitute pol
in in
vitro base excision repair (BER), suggesting that pol
participates in BER. Pol
is the main pol involved in the BER of
lesions generated by monofunctional alkylating agents in eukaryotic
nuclear DNA, and pol
was proposed to be involved in the other types
of BER (5). However, understanding the possible physiological roles of
this enigmatic pol would require a complete characterization of the
biochemical properties of the endogenous enzyme. In this study, we
describe, for the first time, the isolation of endogenous pol
from
a mammalian tissue. Remarkably, this activity was isolated by an
activity assay that uses damaged DNA as a template, suggesting a
possible role of pol
in DNA repair and translesion synthesis.
![]()
MATERIALS AND METHODS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS AND DISCUSSION
REFERENCES
,
, and
. For the preparation of
the apurinic poly(dA)/oligo(dT) template, an incubation time of 40 min
was selected, corresponding to a loss of 80% DNA synthesis efficiency
by pols
and
and 73% by pol
if compared with the
corresponding non-damaged poly(dA)/oligo(dT).
protein was purchased from NeoMarkers (Freemont, CA). The
rabbit polyclonal antibody against mouse pol
was a gift from L. Blanco (Madrid, Spain).
80 °C until further use.
or pol
. In this case, about 250-300 nucleotides were incorporated per DNA template, although for calculation of the
error rate, it was necessary to fill 250 nucleotides of 350 gapped.
Replication reactions for the reverse mutation assay were carried out
for 10 min by using as a template M13mp2T90 DNA with an additional
26-mer oligonucleotide. All other conditions were identical to the
forward mutation assay.
![]()
RESULTS AND DISCUSSION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS AND DISCUSSION
REFERENCES

View larger version (25K):
[in a new window]
Fig. 1.
Purification of a 67-kDa DNA polymerase from
calf thymus detergent extract that preferentially replicates damaged
DNA. A, flow chart of the purification procedure (for
details, see "Materials and Methods"). F, fraction.
B, chromatographic separation of a pol that is
preferentially active on damaged DNA from the classical pols. The
second, minor peak (arrow, eluting between 250 and 350 mM potassium phosphate) shows similar pol activity on
non-damaged DNA and on damaged DNA. The specific activities were 7.6 units/mg on non-damaged DNA and 5.1 units/mg on damaged DNA. The pooled
fractions 12-17 were used for further purification. C, the
last chromatography step, the mono S column. The pol activity eluted
between 350 and 300 mM NaCl on mono S column as one peak.
The pol activity was 2064 units/mg on damaged DNA versus
1040 units/mg on non-damaged DNA (details of chromatographic behavior
are described under "Materials and Methods"). D,
fractions V and VI analyzed in a 12.5% SDS-polyacrylamide gel
electrophoresis and stained with Coomassie Brilliant Blue. Only one
band at a position of 67 kDa was identified in fraction VI.
MWM, molecular weight markers.
--
The final mono S fraction (fraction VI) was analyzed by
immunoblot for a variety of known pols, such as pols
,
,
, and
. No bands were observed with antibodies against pols
,
, and
(data not shown), but a strong signal was discovered for a 67-kDa polypeptide with a monoclonal antibody against human recombinant pol
(Fig. 2A), suggesting that
we had isolated a
-like pol. Next, the same mono S fraction was
tested with an antibody against pol
, and a clear signal was again
obtained for this polypeptide (Fig. 2B). All pols of family
X have very conserved DNA polymerase domains (2); therefore, the
cross-reactivity of pol
with pol
antibody was not unexpected.
Next, we tested whether this 67-kDa polypeptide was responsible for the
polymerase activity. As shown in Fig. 2C, in situ
activity gel analysis showed that the polypeptide corresponding to the
67-kDa band was able to incorporate nucleotides into a DNA template.
These data strongly suggested that the pol isolated from calf thymus
using a damaged DNA as the template is pol
. Accordingly, only pol
among family X pols has an expected molecular mass of 64-67
kDa based on the cDNA sequence of human and mouse.

View larger version (40K):
[in a new window]
Fig. 2.
Identification of the 67-kDa polypeptide as
pol
. A, fractions (F) V and
VI (see panel A of Fig. 1) immunoblotted after 12.5%
SDS-polyacrylamide gel electrophoresis with monoclonal antibodies
against pol
. The pol
antibody cross-reacted with a band at
position 67 kDa in both fractions. The recombinant pol
was used as
a positive control. MWM, molecular weight markers.
B, immunoblot analysis for pol
. Polyclonal antibodies
against pol
cross-reacted with a 67-kDa polypeptide in both
fractions V and VI. C, activity gel analysis performed to
confirm the pol activity in the 67-kDa polypeptide. Fraction VI and pol
were tested in a 12% SDS-PAGE activity gel analysis as described
under "Materials and Methods."
shares
similarity with yeast pol IV and that the C-terminal domain shares similarity with mammalian pol
(2). Although yeast pol IV shows the
properties typical for pol
, the apparent molecular mass of the
polypeptide is larger (68 kDa) (10). Therefore, it is possible that pol
, rather than pol
, is the homolog of yeast pol IV.
--
Since the pol
activity after the last mono S column was low, an optimization and
characterization was performed. These are summarized in Fig.
3. The pH optimum of pol
was 6.5 with
50 mM bis-Tris, Tris-HCl, or 15 mM potassium
phosphate buffers. The Mg2+ optimum was 1.5 mM,
and for Mn2+, it was 0.5 mM. The
Km for the nucleotide substrate (dTTP) was 5.9 µM, and the Vmax was 0.38 pmol/min. The ratio Vmax/Km was 2.57 × 10
3 min
1 × 1 µl
1, which is a lower estimation of
kcat/Km. These results are
significantly different from those for human recombinant pol
, which
has low Km (0.5 µM) for the nucleotide
substrate and optimal conditions for pol activity at pH 7.5 and
10 mM MgCl2 (11). Pol
is resistant to
inhibition by aphidicolin (10, 12); therefore, it was interesting to
examine the purified calf thymus pol
for this inhibitor.
Unexpectedly and in contrast to pol
, pol
was
aphidicolin-sensitive.

View larger version (31K):
[in a new window]
Fig. 3.
Biochemical properties of calf thymus DNA
polymerase
. All pol
assays were performed as
described under "Materials and Methods." 100% of activity
corresponds to 21 units/ml on damaged DNA. A, dependence of
activity on divalent cations. F, fraction. B,
dependence of the activity on the pH in different buffer systems.
C, sensitivity of polymerase activity to aphidicolin. DNA
pol
was inhibited by aphidicolin (big squares). DNA pol
was used in the same experiment as a control for aphidicolin
resistance (small squares). D, dependence of
reaction velocity on dTTP concentration. Curves were fitted to the
experimental points by non-linear least squares fitting.
and
in a Forward and in a
Reverse Mutation Assay--
Pol
is the least accurate classical
mammalian pol, with an average substitution error rate of about
10
3 (13). Human recombinant pol µ (a member of family X
DNA polymerases) is an error-prone pol (14). Replication fidelity of
natural pol
has never been measured before. Therefore, we compared
the fidelity of calf thymus pol
with human recombinant pol
. A 6-fold more accurate synthesis was observed for pol
as
compared with pol
in a forward mutation assay (Table
I) when both base substitution and
frameshift mutation were determined. We have used 2-h gap filling
reactions. Under these conditions, even if neither a 3'
5'
exonuclease nor any other nuclease was identified in pol
fractions,
a very minor proofreading activity could influence the overall fidelity
due to a long incubation. To exclude this probability and estimate
a share of base substitutions from total errors, we used the additional
reverse mutation system on M13mp2T90 DNA with only a 10-min synthesis
(see "Materials and Methods"). The data from Table
II confirmed a 5-fold higher fidelity of
pol
as compared with pol
. Errors can occur during any DNA
synthesis reaction in a cell, including the gap filling synthesis
required for mismatch repair, BER, or nucleotide excision repair. These repair processes require different amounts of DNA resynthesis, catalyzed by pols having very different error rates. The main repair
pol
has an average substitution error rate of about
10
3. If this was the error rate in vivo, only
BER-associated synthesis of pol
would yield about 10 errors per day
(15). However, the fidelity of a complete BER complex must be higher
than that of the pol alone. It was shown that pol
misinsertion
might be proofread by an extrinsic exonuclease (16, 17) or subsequently corrected by some forms of DNA mismatch repair. Furthermore, it was
shown that an alternative BER pathway can utilize pols
and
.
Using nuclear extracts from wild-type and
-pol null mouse fibroblasts, it has been demonstrated that this alternative BER pathway
has a repair patch size of about two to six nucleotides (18). We have
identified pol
from calf thymus as a pol activity scoring better on
damaged versus non-damaged DNA. The facts that pol
can
incorporate nucleotides on damaged DNA and has 5- to 6-fold higher
fidelity than pol
suggest that pol
can contribute substantially
to DNA repair. Thus, based on our results, we suggest that pol
could be responsible for this additional long patch BER pathway. It was
shown recently that human recombinant pol
performs a limited but
significant strand displacement synthesis on gapped DNA substrates, a
capacity that would be essential to allow the participation of pol
in long patch BER (5). It was also shown that human recombinant pol
exhibits 5'-deoxyribose phosphate lyase activity and, in coordination
with its polymerization activity, efficiently repaired
uracil-containing DNA in an in vitro reconstituted
BER reaction. Thus, pol
may participate in single-nucleotide BER in
mammalian cells. The mRNA for human pol
was highly abundant in
testis, although basal levels were detected in all tissues examined
(2). Therefore, and in addition to demonstrating its putative role in
meiotic recombination, it will be relevant to determine whether pol
could also have a role in homologous recombination (e.g.
repair of double-stranded breaks, a process contributing to genetic
stability in somatic cells).
Mutation frequencies of DNA polymerases
and
by the forward
mutation assay
Mutation frequencies of DNA polymerases
and
by the reverse
mutation assay
![]()
ACKNOWLEDGEMENTS
and for critical reading of the manuscript and
Graziella Pedrazzi for help in preparing the figures.
![]()
FOOTNOTES
To whom correspondence should be addressed: Institute of
Veterinary Biochemistry and Molecular Biology, University of
Zürich-Irchel, Winterthurerstrasse 190, CH-8057, Zürich,
Switzerland. Tel.: 41-1-635-54-72; Fax: 41-1-635-68-40; E-mail:
hubscher@vetbio.unizh.ch.
![]()
ABBREVIATIONS
![]()
REFERENCES
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS AND DISCUSSION
REFERENCES
1.
Hübscher, U.,
Maga, G.,
and Spadari, S.
(2002)
Annu. Rev. Biochem.
71,
133-163[CrossRef][Medline]
[Order article via Infotrieve]
2.
García-Díaz, M.,
Domínguez, O.,
López-Fernández, L. A.,
Laín de Lera, T.,
Saníger, M. L.,
Ruiz, J. F.,
Párraga, M.,
García-Ortiz, M. J.,
Kirchhoff, T.,
del Mazo, J.,
Bernad, A.,
and Blanco, L.
(2000)
J. Mol. Biol.
301,
851-867[CrossRef][Medline]
[Order article via Infotrieve]
3.
Bork, P.,
Hofmann, K.,
Bucher, P.,
Neuwald, A. F.,
Altschul, S. F.,
and Koonin, E. V.
(1997)
FASEB J.
11,
68-76[Abstract]
4.
Zhang, X.,
Moréra, S.,
Bates, P. A,
Whitehead, P. C.,
Coffer, A. I.,
Hainbucher, K.,
Nash, R. A.,
Sternberg, M. J. E.,
Lindahl, T.,
and Freemont, P. S.
(1998)
EMBO J.
17,
6404-6411[CrossRef][Medline]
[Order article via Infotrieve]
5.
García-Díaz, M.,
Bebenek, K.,
Kunkel, T. A.,
and Blanco, L.
(2001)
J. Biol. Chem.
276,
34659-34663 6.
Kunkel, T. A.
(1984)
Proc. Natl. Acad. Sci. U. S. A.
81,
1494-1498 7.
Laemmli, U. K.
(1970)
Nature
227,
680-685[CrossRef][Medline]
[Order article via Infotrieve]
8.
Towbin, H.,
Staehelin, T.,
and Gordon, J.
(1979)
Proc. Natl. Acad. Sci. U. S. A.
76,
4350-4354 9.
Spanos, A.,
Sedgwick, S. G.,
Yarranton, G. T.,
Hübscher, U.,
and Banks, G. R.
(1981)
Nucleic Acids Res.
9,
1825-1839 10.
Shimizu, K.,
Santocanale, C.,
Ropp, P. A.,
Longhese, M. P.,
Plevani, P.,
Lucchini, G.,
and Sugino, A.
(1993)
J. Biol. Chem.
268,
27148-27153 11.
García-Díaz, M.,
Bebenek, K.,
Sabariegos, R.,
Domínguez, O.,
Rodriguez, J.,
Kirchhoff, T.,
García-Palomero, E.,
Picher, A. J.,
Raquel, J.,
Ruiz, J. F.,
Kunkel, T. A.,
and Blanco, L.
(2002)
J. Biol. Chem.
277,
13184-13191 12.
Waser, J.,
Hübscher, U.,
Kuenzle, C. C.,
and Spadari, S.
(1979)
Eur. J. Biochem.
97,
361-368[Medline]
[Order article via Infotrieve]
13.
Osheroff, W. P.,
Jung, H. K.,
Beard, W. A.,
Wilson, S. H.,
and Kunkel, T. A.
(1999)
J. Biol. Chem.
274,
3642-3650 14.
Domínguez, O.,
Ruiz, J. F.,
Laín de Lera, T.,
García-Díaz, M.,
González, M. A.,
Kirchhoff, T.,
Martínez-A, C.,
Bernad, A.,
and Blanco, L.
(2000)
EMBO J.
19,
1731-1742[CrossRef][Medline]
[Order article via Infotrieve]
15.
Kunkel, T. A.,
and Bebenek, K.
(2000)
Annu. Rev. Biochem.
69,
497-529[CrossRef][Medline]
[Order article via Infotrieve]
16.
Höss, M.,
Robins, P.,
Naven, T. J. P.,
Pappin, D. J. C.,
Sgouros, J.,
and Lindahl, T.
(1999)
EMBO J.
18,
3868-3875[CrossRef][Medline]
[Order article via Infotrieve]
17.
Shevelev, I. V.,
Belyakova, N. V.,
Kravetskaya, T. P.,
and Krutyakov, V. M.
(2000)
Mutat. Res.
459,
237-242[Medline]
[Order article via Infotrieve]
18.
Stucki, M.,
Pascucci, B.,
Parlanti, E.,
Fortini, P.,
Wilson, S. H.,
Hübscher, U.,
and Dogliotti, E.
(1998)
Oncogene
17,
835-843[CrossRef][Medline]
[Order article via Infotrieve]
Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
K. A. Fiala, W. W. Duym, J. Zhang, and Z. Suo Up-regulation of the Fidelity of Human DNA Polymerase {lambda} by Its Non-enzymatic Proline-rich Domain J. Biol. Chem., July 14, 2006; 281(28): 19038 - 19044. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Maga, I. Shevelev, G. Villani, S. Spadari, and U. Hubscher Human replication protein A can suppress the intrinsic in vitro mutator phenotype of human DNA polymerase {lambda} Nucleic Acids Res., March 6, 2006; 34(5): 1405 - 1415. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Takeuchi, T. Ishidoh, H. Iijima, I. Kuriyama, N. Shimazaki, O. Koiwai, K. Kuramochi, S. Kobayashi, F. Sugawara, K. Sakaguchi, et al. Structural relationship of curcumin derivatives binding to the BRCT domain of human DNA polymerase {lambda} Genes Cells, March 1, 2006; 11(3): 223 - 235. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. McVoy and D. E. Nixon Impact of 2-Bromo-5,6-Dichloro-1-{beta}-D-Ribofuranosyl Benzimidazole Riboside and Inhibitors of DNA, RNA, and Protein Synthesis on Human Cytomegalovirus Genome Maturation J. Virol., September 1, 2005; 79(17): 11115 - 11127. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. K. Braithwaite, R. Prasad, D. D. Shock, E. W. Hou, W. A. Beard, and S. H. Wilson DNA Polymerase {lambda} Mediates a Back-up Base Excision Repair Activity in Extracts of Mouse Embryonic Fibroblasts J. Biol. Chem., May 6, 2005; 280(18): 18469 - 18475. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Hashimoto, Y. Tominaga, Y. Nakabeppu, and M. Moriya Futile short-patch DNA base excision repair of adenine:8-oxoguanine mispair Nucleic Acids Res., November 5, 2004; 32(19): 5928 - 5934. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Shevelev, G. Blanca, G. Villani, K. Ramadan, S. Spadari, U. Hubscher, and G. Maga Mutagenesis of human DNA polymerase {lambda}: essential roles of Tyr505 and Phe506 for both DNA polymerase and terminal transferase activities Nucleic Acids Res., December 1, 2003; 31(23): 6916 - 6925. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Maga, G. Villani, K. Ramadan, I. Shevelev, N. T. Le Gac, L. Blanco, G. Blanca, S. Spadari, and U. Hubscher Human DNA Polymerase lambda Functionally and Physically Interacts with Proliferating Cell Nuclear Antigen in Normal and Translesion DNA Synthesis J. Biol. Chem., December 6, 2002; 277(50): 48434 - 48440. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |